TickerFactsScreenerDevelopers

ZEVRA THERAPEUTICS, INC. (ZVRA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $2.54M2013: $1.97M2014: $10.26M2015: $32.32M2016: $16.76M2017: $10.87M2018: $18.41M2019: $3.22M2020: $4.21M2021: $112.35M2022: $65.47M2023: $43.05M2024: $33.78M2025: $62.41M$62.41M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$62.41M+84.7%
2024$33.78M-21.5%
2023$43.05M-34.2%
2022$65.47M-41.7%
2021$112.35M+2566.7%
2020$4.21M+31.0%
2019$3.22M-82.5%
2018$18.41M+69.3%
2017$10.87M-35.1%
2016$16.76M-48.1%
2015$32.32M+215.1%
2014$10.26M+420.8%
2013$1.97M-22.5%
2012$2.54M—